Renowned Speakers

We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.

Prof. Giuseppe Spriano

Director, Otorhinolaryngology Head Italy

Biography

Prof. Alexis Andrew Miller

Radiation Oncologist Australia

Biography

Dr. Sarin Kitpanit

Radiation Oncologist Thailand

Biography

Dr. Loren Mell

Tenured Professor and Vice-Chair of Clinical & Translational Research USA

Biography

Dr. Kenneth Jensen

Associate Professor Denmark

Biography

Margaret Hjorth

Icon Group Cancer Services Australia

Biography

Sherry A. Bradford

AccuTheranostics, Inc., USA

Biography

Bronislaw L Slomiany

University of Medicine and Dentistry of New Jersey USA

Biography

Conference Information

Welcome Message

We are delighted to invite you to the "2^nd International Conference on Oncology and Cancer Research," which will be held in London, UK, from June 27–28, 2024. Oncology Conferences 2024 promise to be a remarkable event as we bring together cancer specialists, researchers, medical professionals, and activists from all around the world.

Our objective is to offer a forum for discussing the most recent developments, perceptions, and discoveries in oncology and cancer research. We think that by bringing together specialists from different domains, we can develop a vibrant environment for learning and teamwork, which will eventually result in improved treatment for cancer patients.

The conference program is packed with thought-provoking sessions, keynote presentations, panel discussions, and interactive workshops. The sessions will cover various topics, including the latest in cancer treatment, advancements in cancer research, and emerging trends in cancer care.

We are confident that this year's conference will offer a valuable opportunity to engage with like-minded professionals, network with colleagues, and gain valuable insights into the field of oncology. We look forward to your presence at Oncology 2024.

Scientific Sessions

Oncology

The medical specialty that addresses cancer prevention, diagnosis, and treatment is called oncology. Physicians who focus on treating cancer are known as oncologists. They collaborate closely with surgeons, radiologists, pathologists, and other medical specialists to create comprehensive treatment plans for their patients. Treatments for cancer can take many different forms, such as immunotherapy, targeted therapy, hormone therapy, surgery, radiation therapy, chemotherapy, and stem cell transplants. The patient's overall health, their personal preferences, and the type and stage of their cancer all play a role in the treatment decision.

Related Journals: Journal of Clinical Oncology, Clinical Cancer Research, Cancer Journal for Clinicians, Journals of Oncology Conferences 2023, Journal of Thoracic Oncology, European Journal of Cancer, British Journal of Cancer, Cancer Immunology, Immunotherapy Conferences and Cancer Research Conferences and Treatment

Clinical Oncology

The diagnosis and treatment of cancer in patients is the focus of the oncology subspecialty known as clinical oncology. Clinical oncologists are physicians with specialized training in the management of cancer patients. This includes the application of different treatment modalities like targeted therapy, radiation therapy, immunotherapy, chemotherapy, and other systemic therapies.

To provide comprehensive and well-coordinated care for cancer patients, clinical oncologists collaborate closely with other medical specialists such as radiologists, pathologists, surgeons, and nurses. They assess patients, identify the kind and stage of the disease, and create a customized treatment plan based on the requirements of each patient.

Oncology Nursing

The care of patients with cancer is the primary focus of the specialty nursing field known as oncology nursing. Clinics, outpatient facilities, and hospitals are just a few of the places where oncology nurses are employed. They assist patients with emotional support, managing symptoms, and educating them about cancer and available treatments, all of which are vital aspects of their cancer journey. With a strong commitment to patient care and a desire to improve the lives of cancer patients, oncology nursing is an all-around challenging but rewarding profession.

Organ-Defined Cancers

An organ or tissue is the source of an organ-defined cancer, which is a class of cancers with a named diagnosis. A few instances of cancers that are classified according to their organs are skin, lung, breast, colon, and prostate cancers. Diverse risk factors, symptoms, and treatment options are among the distinctive features of each type of cancer that is defined by an organ. For example, age, family history, lifestyle, and other factors may play a role in breast cancer, which is more common in women, but tobacco use is substantially associated with lung cancer. Enhancing the precision of diagnosis and staging, creating novel and more potent treatments, and figuring out how to stop and lower the risk of organ-defined cancers are the main goals of ongoing research in this area.

Innovations in Cancer Research

Considerable progress has been made in our knowledge and management of cancer thanks to innovations in cancer research. Targeted therapies that precisely address the distinct genetic characteristics of each patient's cancer have become possible thanks to advancements in precision medicine and immunotherapy, which have improved treatment outcomes. In terms of identifying cancer cells and adjusting the immune system to combat cancer, liquid biopsies and CAR-T therapy have also demonstrated encouraging outcomes. Cancer therapy may undergo a revolution as a result of the advancement of CRISPR gene editing technology, which has also created new avenues for targeted cancer treatments. The prospects of better treatment options, better patient outcomes, and perhaps even a cancer cure in the future are all made possible by the ongoing advancements in cancer research.

Biomarkers of Cancer Stem Cells

These cells can be distinguished from other tumor cells using biomarkers specific to cancer stem cells. Specific cell surface markers or genetic mutations specific to cancer stem cells could be examples of these biomarkers. Researchers can create targeted therapies to eradicate cancer stem cells and learn more about the biology of these cells by examining these biomarkers.

Additionally, the development of the disease and the response to treatment can be tracked using biomarkers of cancer stem cells. When making decisions about treatment and evaluating the efficacy of therapy, they can offer information regarding the existence and activity of cancer stem cells both before and after treatment.

All things considered, cancer stem cell biomarkers present a viable path toward bettering cancer detection, therapy, and tracking. They could improve our knowledge of cancer stem cells and eventually help cancer patients receive better care.

Cancer Nanotechnology

Using nanoparticles to enhance cancer detection, diagnosis, and treatment is a developing field known as "cancer nanotechnology." The size of nanoparticles, which can be engineered to specifically interact with cancer cells or tissues, is between one and one hundred nanometers.

MRIs and PET scans are two imaging modalities that can be enhanced with nanoparticles to help detect cancer earlier and with greater accuracy. Chemotherapy can be administered more effectively and with fewer side effects when drugs are delivered directly to cancer cells using nanoparticles. Moreover, by administering immunotherapies to cancer cells directly or acting as adjuvants that strengthen the immune system's capacity to identify cancer, nanoparticles can be utilized to improve the immune response to cancer.

Generally speaking, cancer nanotechnology presents a viable strategy for enhancing cancer identification, diagnosis, and therapy. By enhancing patient outcomes and quality of life, it may revolutionize cancer therapy.

Cancer Clinical Trials

Research projects called cancer clinical trials test novel cancer therapies or interventions. The development of novel cancer therapies and the enhancement of patient outcomes depend on these trials. New medications, radiation therapy, surgery, and other therapies are just a few of the interventions that can be tested in clinical trials. Additionally, they might entail combining already-effective therapies or changing already effective therapies. All things considered, the development of novel cancer treatments and the advancement of oncology depend heavily on cancer clinical trials. In addition to giving patients the chance to participate in the fight against cancer, they offer hope for better patient outcomes and a higher quality of life.

Neuro-Oncology

Cancers affecting the brain and nervous system are the main focus of the medical specialty known as neuro-oncology. Often referred to as primary brain tumors or central nervous system tumors, these cancers may start in the brain or spinal cord or may be the product of cancer cells that metastasized from other areas of the body. Multiple specialties, including neurosurgeons, radiation oncologists, medical oncologists, neurologists, and others, are frequently involved in the management of neuro-oncological tumors. Surgery, chemotherapy, radiation therapy, or a mix of these treatments could be part of the treatment plan.

Head/Neck Cancer

A number of cancers that arise in the oral cavity (mouth), pharynx (throat), larynx (voice box), salivary glands, nasal cavity, and sinuses are collectively referred to as head and neck cancers. Squamous cell carcinomas are the common name for these cancers, which typically begin in the squamous cells that line the moist surfaces of the head and neck. A low fruit and vegetable diet, exposure to the human papillomavirus (HPV), smoking, drinking alcohol, and having a compromised immune system are risk factors for head and neck cancer. Chemotherapy, radiation therapy, and/or surgery are frequently used in conjunction for treating head and neck cancer.

Blood Cancer

The development and function of your platelets are impacted by blood cancer. As blood is delivered to the bone marrow, most of these diseases begin there. Micro influences at an immature stage: organisms in your bone marrow develop into red, white, or platelets. Most blood diseases cause an uncontrolled development of a peculiar type of platelet that impedes the normal platelet improvement process. Your blood cannot carry out many of its functions, including protecting against infection and preventing serious death, because of these abnormal platelets, or harmful cells.

Breast Cancer

Different parts of the breast can give rise to breast tumors. Perched above the upper ribs and chest muscles is an organ called the bosom. Everybody has greasy tissue, conduits, and organs in addition to having a left and right breast. Ladies, the breasts produce and distribute milk to nourish infants and young children. Each breast has a different size depending on the amount of greasy tissue in the bosom. The treatment for it is based on the stage of the illness. It may include medical procedures, chemical treatment, radiation, and chemotherapy.

Oral and Oropharyngeal cancer

The center portion of your throat, the oropharynx (pharynx), is where oropharyngeal cancer is a malignant growth. Other side effects include a white patch in the mouth, hacking up blood, a bump in the throat, mouth, or neck, and a sensitive throat that doesn't go away. A medical procedure, radiation therapy, chemotherapy, a specific medication, and immunotherapy are examples of therapies. Malignant growth cells are found inside the oropharynx, a region of the throat, in oropharyngeal cancer, a type of head and neck malignant growth. More than 90% of malignant growths that arise from the surface cells covering your mouth and throat are called squamous cell carcinomas, or oropharyngeal cancers.

Colon Cancer

The rectum and colon can be affected by colon cancer, commonly referred to as colorectal cancer. If treatment is not received, it could spread to other areas of the body as a result of abnormal cells in the colon or rectum growing out of control. Colostrum and inflammatory bowel disease are personal histories; a diet heavy in red meat or processed foods, a sedentary lifestyle, and a family history of the disease are risk factors for colon cancer. Weight loss, blood in the stool, stomach pain, and altered bowel habits are some of the symptoms.

Pelvic Cancer

The term "pelvic cancer" refers to any malignant growth that starts in a woman's reproductive system. The uterine, vaginal, cervical, ovarian, and vulvar cancers are the five main disease types that affect a woman's reproductive organs. They are referred to collectively as gynecologic diseases. The incredibly fascinating fallopian tube disease is a sixth type of gynecologic malignant growth. Better locations for the five gynecologic tumors are inside a woman's pelvis, which is the area between her hip bones and beneath her stomach. Every gynecologic illness is unique, with a range of symptoms and side effects, risk factors, and methods for anticipation. The risk of gynecologic malignant growths increases with age for all women. Therapy begins when gynecologic malignant growths are thought to be premature.

Skin Cancer

Skin Cancer: Unrepaired DNA damage that sets off changes causes abnormal cells to proliferate erratically in the epidermis, the outermost layer of skin. These modifications cause the skin's cell count to rise swiftly and give rise to dangerous cancers. Merkel cell carcinoma (MCC), melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC) are the four main types of skin cancer. Thankfully, if skin cancer is detected early enough, your dermatologist can treat it with minimal scarring and a high likelihood of curing it entirely. Often, the physician will attempt to detect the growth at a precancerous stage, before it has progressed to a more serious skin condition or penetrated beneath the epidermis.

Regenerative Medicine

The process of regenerating, replacing, creating, or restoring human tissues, cells, or organs to restore or arrange normal functions is related to regenerative medicine. In order to improve our understanding of malignant growth science, the field of regenerative medicine involves the development of disease models, tissue design, cell treatment, quality control, and involvement in malignant growth therapy.

Herbal Treatment for Cancer

Herbal medicine treats disease and enhances well-being by using plants or plant extracts. It cannot be justified as a treatment for a medical condition because there is insufficient logical evidence. Drug interactions and unfavorable side effects are possible with herbal remedies. Prescriptions made from home grown plants may not be directed and may have different contents when made outside of the UK. If you choose to purchase homemade remedies from a fully licensed herbal practitioner, it is the safest option.

Cancer Immunology

The study of cancer immunology focuses on how the immune system reacts to cancer cells and how this reaction may be used to create novel cancer therapies. Identification and removal of aberrant cells, including cancer cells, are vital functions of the immune system. Cancer cells, however, can employ a number of evasive tactics to avoid immune system recognition, such as inhibiting the production of molecules that promote immune cell activity or suppressing the immune response. An effective cancer treatment that tries to strengthen the immune system's ability to combat cancer cells is immunotherapy. When it comes to the development of novel cancer treatments, cancer immunology is one of the most promising fields of study in the field.

Advancements in Cancer Treatment

Numerous scientific and technological developments have led to significant advancements in the treatment of cancer in recent years. Using the patient's own immune system to combat cancer cells, immunotherapy has become a promising new treatment option for the disease. Physicians can customize treatment to a patient's specific genetic profile thanks to targeted therapy and precision medicine. Advances in radiation therapy and minimally invasive surgery have improved the efficacy and reduced the invasiveness of CAR-T therapy, which has demonstrated great promise for treating specific types of leukemia and lymphoma. On the basis of each patient's distinct genetic profile, personalized cancer vaccines are also being developed, which instruct the immune system on how to identify and combat cancer cells.

Tumor vs Cancer

While they have some similarities, the terms tumor and cancer are not the same. Unusual cell growth, known as a tumor, can be malignant (cancerous) or benign (not harmful). Generally not life-threatening, benign tumors do not metastasize to other parts of the body. By applying pressure to surrounding tissues or organs, they can still be problematic. Nevertheless, the unchecked development and dissemination of aberrant cells is the hallmark of cancer. Cancer cells can travel to other areas of the body by the lymphatic or circulatory systems, as well as by invading adjacent tissues and organs. Cancer may pose a life-threatening threat if untreated.

Chemotherapy

Using potent chemicals to destroy rapidly proliferating cells within your body is known as chemotherapy. When compared to other body cells, cancer cells proliferate and spread much more quickly, making chemotherapy the treatment of choice. Chemotherapy medications come in many varieties. Chemotherapy medications can be given alone or in combination to treat a variety of tumor types. Chemotherapy carries some risk of side effects, despite being an effective treatment for many cancer types. There are some side effects of chemotherapy that are easily managed, while there are others that may be fatal.

Market Analysis

The rising oncology trouble across the globe inferred from the expanded utilization of liquor and tobacco is driving the development of the worldwide oncology market. The Worldwide Organization for Exploration on Malignant Growth (IARC), in its report GLOBOCAN, has expressed that around 19.3 million new disease cases and around 10 million deaths connected with the disease were recorded in 2020 across the globe. The IARC has assessed that the new malignant growth cases are supposed to ascend by 47% all around the globe from 2020 to 2040. Oncology Therapeutics alone accounts for around 20% of the worldwide sales of the drugs. Around the world, chronic diseases are the essential drivers of mortality and incapacity. Chronic diseases represent around 60% of passing and 43% of worldwide sickness trouble, as per the WHO's Worldwide Status Report on Non-Transferable Infections 2010. Constant illnesses are long-haul, moderate afflictions that are among the most costly and normal medical service difficulties on the planet.

About Conference

Oncology 2024 invites every one of the members from everywhere in the world to go to the 2^nd International Conference on Oncology and Cancer Research from June 27–28, 2024, in London, UK. The meeting incorporates feature introductions, oral discussions, banner introductions, and displays.

The gathering is focused on oncologist specialists and other medical care experts who are engaged with cancer, breast cancer specialists, chronic disease surgeons, and lung specialists.

Oncology 2024 will be useful for the experts to pass on their points and experiences that are connected to medical procedures, such as cancer, lung cancer, breast cancer, chemotherapy, and so on.

The fundamental intention of the meeting is to investigate the latest research on oncology and cancer research medical procedures alongside protected, compelling, and reasonable use. The speakers and agents investigate the information through paper shows, banner shows, speaker gatherings, and talks by dynamic specialists to foster hypothetical and down-to-earth abilities.

2nd International Conference on
Oncology and Cancer Research

Quick Links

Theme: Explore the Latest Research on Oncology and Cancer

Renowned Speakers

Conference Information

Welcome Message

Scientific Sessions

Market Analysis

About Conference